LLY Jun 2025 1060.000 put
| Previous Close | 201.50 |
| Open | 201.50 |
| Bid | 0.00 |
| Ask | 0.00 |
| Strike | 1,060.00 |
| Expire Date | 2025-06-20 |
| Day's Range | 201.50 - 201.50 |
| Contract Range | N/A |
| Volume | |
| Open Interest | N/A |
- Yahoo Finance Video
Hims & Hers stock falls after Eli Lilly's weight-loss drug dropped from shortage list
Eli Lilly (LLY)'s weight loss drugs Mounjaro and Zepbound are no longer facing supply constraints, as the FDA has removed them from its shortage list — signaling the pharmaceutical giant's ability to now meet market demand. In contrast, shares of competitor Hims & Hers Health (HIMS) are plummeting following this news. Market Domination hosts Madison Mills and Josh Schafer discuss the news and Citi's take on it. For more expert insight and the latest market action, click here to watch this full episode of Market Domination. This post was written by Angel Smith
Investor's Business DailyAs Weight-Loss Drugs Battle, Upstart Viking Therapeutics Threatens Eli Lilly, Novo Nordisk, Pfizer
Viking Therapeutics stock is on the rise as the battle to develop new weight-loss drugs heats up. Here's what's at stake for the pharma giants fighting for position.
Investor's Business DailyTop T. Rowe Price Fund Manager Shares Her Secrets
Stock picking is the hallmark of top mutual fund T. Rowe Price U.S. Equity Research Fund (PRCOX). But what makes this top stock mutual fund unique is that it's not the fund managers who pick the stocks that make it into the portfolio.
